Related Experiment Videos
Pharmacological management of depression in patients with cancer: practical considerations
Riccardo G V Torta1, Valentina Ieraci
1Department of Neuroscience, Clinical and Oncological Psychology Unit, Città della Salute e della Scienza, University of Turin, Corso Bramante 88/90, 10126, Turin, Italy. riccardo.torta@unito.it
Abstract:
This article provides an overview of the prevalence, pathogenesis and diagnosis of, and treatment strategies for, depression in cancer patients. Untreated depression can increase the burden of oncology symptoms and worsen the cancer prognosis through the relationship between mood and immunity. The issues to consider when treating a patient with cancer who has depression include when to introduce pharmacotherapy, the criteria for choosing an antidepressant, and the necessary caution regarding side effects and drug interactions. The choice of an antidepressant is a complex decision that has to balance previous pharmacological experiences, different clusters of target symptoms, pharmacological interactions, and objective and subjective risks of side effects, with the aim of tailoring a strategy for each patient.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Therapeutic Drug Monitoring: Affecting Factors
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...